Home › Metabolic › Semaglutide (10mg)
Metabolic Research Peptide
GLP-1 receptor agonist · Research-grade, Australia
In stock · dispatched Australia-wide
View & buy on store →Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist sharing approximately 94% structural homology with native human GLP-1. This 10mg presentation supports laboratory research into glucose regulation, insulin secretion modulation, and appetite signalling pathways in pre-clinical models.
Dose-response characterisation is where the 10 mg presentation earns its place. Work on GLP-1 receptor agonists in vitro generally means a serial dilution series across several log units, and the number of usable points in that series is limited by how much material a single lot provides. At 10 mg a full dilution ladder plus vehicle controls and repeat runs can be prepared from one vial and one batch number, so the resulting curve is not stitched together from lots of differing purity.
| Compound | Semaglutide |
|---|---|
| Category | Metabolic |
| CAS Number | 910463-68-6 |
| Form | Lyophilised Powder |
| Appearance | White to off-white solid |
| Purity | 99.583% (this batch) |
| Batch | CS-sg10-1553 |
| Analytical methods | HPLC (purity), mass spectrometry (identity) |
| Solubility (research) | Reconstitutes in bacteriostatic or sterile water |
Batch-specific analytical values are recorded on the Certificate of Analysis supplied with the compound.
Semaglutide is supplied as a lyophilised powder for reconstitution in bacteriostatic or sterile water. The peptide is acylated and comparatively hydrophobic, so it dissolves more slowly than a short unmodified peptide — add diluent gently and give the cake time to clear rather than shaking it. At 10 mg, reconstituting into 2 mL is a common starting point because it produces a 5 mg/mL stock that dilutes cleanly by factors of ten.
Stock concentrations from a single 10 mg vial, for planning a serial dilution series:
| 1 mL of diluent | 10 mg/mL stock |
|---|---|
| 2 mL of diluent | 5 mg/mL stock |
| 2.5 mL of diluent | 4 mg/mL stock |
| 5 mL of diluent | 2 mg/mL stock |
In-vitro stock concentrations for laboratory dilution work. Not dosing information.
Same compound, same analytical methods, same storage profile as the 5 mg presentation; the difference is how much dilution series one lot will support. A 5 mg vial covers a single characterisation run or a narrow concentration range. A 10 mg vial covers a wider ladder with replicates and controls from one batch number, which is what matters if the output is a curve rather than a single-point result.
For comparative work across the incretin class, the tirzepatide and retatrutide presentations are the usual reference points — dual and triple receptor agonists respectively, against semaglutide's single-receptor profile.
Every batch supplied by Vital Research Labs is analysed by an independent third-party laboratory. Purity is confirmed by high-performance liquid chromatography (HPLC) and identity by mass spectrometry (MS). This batch is verified at 99.583% purity, and a Certificate of Analysis is available for the batch so researchers can verify exactly what they are working with.
Semaglutide is dispatched from within Australia to Australian research customers, packaged discreetly and appropriately for a lyophilised research compound. Orders are processed on receipt of payment via bank transfer.
Yes. Vital Research Labs supplies research-grade Semaglutide (10mg) to Australian research customers, dispatched domestically. It is provided strictly for in-vitro laboratory research and is not for human or veterinary use.
This batch is verified at 99.583% purity by third-party analytical testing (HPLC for purity, mass spectrometry for identity). A Certificate of Analysis is available for the batch.
Each batch is analysed by an independent third-party laboratory using HPLC to confirm purity and mass spectrometry to confirm identity. Batch-specific values are recorded on the Certificate of Analysis.
The lyophilised powder is stored at -20 degrees C, protected from light and moisture. Once reconstituted for research it is kept at 2-8 degrees C and typically used within 28 days.
No. Semaglutide (10mg) supplied by Vital Research Labs is intended strictly for in-vitro laboratory research and development. It is not a medicine or therapeutic good and is not for human consumption, veterinary use, or clinical application.
Vital Research Labs supplies Semaglutide from Australian stock, dispatched from New South Wales. Orders placed before the daily cut-off are dispatched the same business day, Monday to Friday, with tracked delivery Australia-wide including Sydney, Melbourne, Brisbane, Perth and Adelaide.
Orders are dispatched the same business day payment is confirmed, Monday to Friday. Weekend and public holiday orders are dispatched the next business day. Standard and express options are available, and express shipping is free on orders over $200. Every order is sent tracked.
Yes. All orders are packed in plain, unbranded outer packaging with no indication of the contents, and sent tracked via Australia Post or an equivalent carrier.
We accept Visa, Mastercard and American Express, plus Apple Pay and Google Pay, all taken instantly at checkout. Bank transfer is also available if you prefer.
Reconstituting 10mg in 1mL of bacteriostatic water gives 10mg/mL; 2mL gives 5mg/mL; 2.5mL gives 4mg/mL; and 5mL gives 2mg/mL. These are in-vitro stock concentrations for laboratory dilution work only.
Chiefly for dose-response work. A wider serial dilution series with replicates and vehicle controls can be prepared from one 10mg lot, so the curve is not assembled from separate batches of differing purity. For a single-point or narrow-range experiment the 5mg vial is sufficient.
Generally yes. Semaglutide is acylated and comparatively hydrophobic, so the lyophilised cake dissolves more slowly than a short unmodified peptide. Add diluent gently against the vial wall and allow it to clear without agitation rather than shaking or vortexing.